PTPN22 and cancer: One of the first works that deals with baculoviruses as a vector for the development of cancer therapies is based on the construction of a baculovirus that display the sequence of the LyP-1 tumor localizing peptide and the reading frames of the transmembrane (TM) and cytoplasmic (CT) domains from VSV-G.